Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

shankar besta

  • Home
  • Author: shankar besta

NanoVibronix’s UroShield trial results hold potential to advance urinary care, says GlobalData

NanoVibronix has recently announced the successful completion of the pilot phase of its UroShield clinical trial in the US. The UroShield device is a novel ultrasonic technology that is designed to reduce catheter-associated complications such as infections, blockages, and discomfort. By generating low-frequency ultrasound waves, the device prevents bacterial colonization and biofilm formation, addressing persistent […]
Read more

Ultra-long acting GLP-1R agonists to become future therapeutic options for obesity, says GlobalData

At present, the obesity market is dominated by once-weekly, subcutaneously injectable medicines agonizing the glucagon-like peptide 1 receptor (GLP-1R), and in the case of Eli Lilly’s Zepbound/Mounjaro (tirzepatide), also the gastric inhibitory peptide receptor (GIPR). Although most patients seem to be satisfied with the currently available medicines, a weekly injection can sometimes be a burden […]
Read more

APAC petrol engines market to decline at negative 5.8% CAGR over 2024-29, forecasts GlobalData

Asian countries have demonstrated a proactive approach in implementing policies that foster the growth of the electric vehicle (EV) market, aimed at environmental sustainability and enhanced competitiveness in the global automotive manufacturing and export sectors. This strategy is contributing to a declining demand for traditional internal combustion engines (ICEs), especially in the passenger car segment. […]
Read more

Delivery platforms enabling smaller foodservice operators in APAC to compete with large brands, says GlobalData

Large foodservice chains have always had an advantage over smaller operators in terms of brand visibility and delivery. However, the advent of food delivery platforms has significantly altered the competitive dynamics in the foodservice sector. The COVID-19 pandemic gave a fillip to the food delivery business, and they have been able to sustain consumer interest. […]
Read more

Eli Lilly’s Zepbound holds potential to dominate obesity market, says GlobalData

It has been a year since the launch of Zepbound (tirzepatide) for obesity, and Eli Lilly’s competition with Novo Nordisk continues. Zepbound’s superior efficacy and strategic market expansion suggest that the drug will dominate the obesity market, surpassing Novo Nordisk’s Wegovy (semaglutide), according to GlobalData, a leading data and analytics company. Recently, Eli Lilly announced […]
Read more

Malaysia ICT market revenue to witness 15.5% CAGR over 2023-28, forecasts GlobalData

The enterprise information and communication technology (ICT) market in Malaysia is projected to grow at a compound annual growth rate (CAGR) of 15.5% over 2023-28, driven by the ongoing digital transformation efforts of businesses and the government, forecasts GlobalData, a leading data and analytics company. GlobalData’s latest report “Malaysia Enterprise ICT Country Intelligence Report,” reveals […]
Read more

Digitalization could deliver long term benefits to oil and gas industry, says GlobalData

In recent years, the oil and gas industry has progressed from using digital technologies for select use cases to making their entire processes digital. Certain technologies—such as artificial intelligence (AI), blockchain, cloud computing, the Internet of Things (IoT), robotics, and virtual and augmented reality (VR and AR)—are now part of their daily routine. These digitalization […]
Read more

Popularity of cultivated meat on rise in APAC, says GlobalData

The popularity of cultivated meat or lab-grown meat has been steadily increasing in the Asia-Pacific (APAC) region in recent years. Meat is considered an essential source of proteins, lipids, carbohydrates, and vitamins that the body needs to meet its energy requirements. However, traditional animal farming techniques are insufficient to meet the growing demand for meat. […]
Read more

Zorifer poised to fill critical gap in treatment of advanced NSCLC with CNS metastases in China, says GlobalData

China’s National Medical Products Administration (NMPA) has recently approved Zorifer (zorifertinib), an oral epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) specifically for the treatment of non-small cell lung cancer (NSCLC) with CNS metastases. Developed by Alpha Biopharma in collaboration with AstraZeneca, this new treatment option is expected to benefit EGFR-mutated NSCLC patients with different […]
Read more

Influencers discuss arrival of AGI as OpenAI’s o3 model ignites AI hype, reveals GlobalData

OpenAI’s recent unveiling of its new o3 reasoning model has ignited a fierce debate among influencers on social media. While many express awe at its impressive performance across various benchmarks, including exceeding human performance on coding and scientific reasoning tasks, others raise concerns about its high cost and the potential for overhyping its artificial general […]
Read more

Targeted therapies and improved diagnostics remain as unmet needs in T2-low asthma, says GlobalData

Despite advances in biologic therapies for severe asthma, significant unmet needs in asthma management remain, specifically with T-helper cell type 2 (T2)-low asthma, a subtype lacking typical inflammatory biomarkers. T2-low asthma presents unique challenges due to the absence of eosinophils and immunoglobulin E (IgE), which complicates both diagnosis and treatment. Insights from experts in the […]
Read more
1 … 51 52 53 54 55 … 136